Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Bio Path Holdings Inc
BPTH
Healthcare
Biotechnology
Bio-Path Holdings, Inc. is a biotechnology company. The Company is engaged in developing DNAbilize, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. DNAbilize, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction...
by the body’s enzymes when circulating in vivo, incorporated inside of a lipid bilayer having neutral charge. Its lead product candidate, prexigebersen (BP1001, targeting the Grb2 protein), is in a Phase II study for blood cancers, and BP1001-A, a drug product modification of prexigebersen, is in a Phase I/Ib study for solid tumors. The Company’s second product, BP1002, which targets the Bcl-2 protein, is being evaluated for the treatment of blood cancers and solid tumors, including acute myeloid leukemia. BP1003 is its third liposome delivered antisense drug candidate.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (PINL:BPTH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 19, 2024 9:08am
Using technical analysis for this stock.
It's looking good for us shareholders today,so good that it is time for you guys out there to buy this one.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 21, 2024 10:03am
BPTH....volume & price action...why u ask ?
Warrants are being exercised.....save ur money tm2412459-1_s1 - none - 4.4375097s (sec.gov)
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 14, 2024 7:00am
New Press Release - Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress
Encore Presentation Highlights Positive Results from Interim Analysis Demonstrating Significant Clinical Improvement and Tolerable Safety Profile for Prexigebersen Combination in High-Risk Patients HOUSTON, June 14, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 05, 2024 5:47pm
New Press Release - Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 04, 2024 4:56pm
New Press Release - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24
Dallas, Texas--(Newsfile Corp. - June 4, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q1 2024. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways...
read article.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 04, 2024 8:53am
BPTH.... You've all been had .... Again !!!!
What a game. That's what you get for being a "Greater Fool" ...otherwise known as a Chaser!!!! Cheers !
(476)
•••
Iseneschal
X
Comment by
Iseneschal
on Jun 04, 2024 8:50am
RE:BPTH.....way too much volume this a.m......
I won the bet ......here is the P.O announcement : Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules 2024-06-04 05:00 ET - News
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 04, 2024 8:00am
New Press Release - Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
HOUSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced...
read article.
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 03, 2024 12:28pm
BPTH.....sub $3 now
N.L.O.D......$2.85
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 03, 2024 10:35am
BPTH...... N.L.O.D
LoL LoL LoL All the a.m opening Chasers got their heads handed back to them in a hand-basket over 44 million shares have traded.....and all it's up is a buck.....Whats wrong with this picture !!
...more
(476)
•••
Iseneschal
X
Comment by
Iseneschal
on Jun 03, 2024 9:57am
RE:BPTH.....Short set up here....JMHO
Not too bags......shorted into the opening strength while the MM was giving as much paper he could to all the Chasers Just covered......for almost a $1 profit per share....Thank you !!!
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 03, 2024 9:25am
BPTH.....Short set up here....JMHO
Waiting for the opening pump to bury all the Chasers ; )
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 03, 2024 9:21am
BPTH.....way too much volume this a.m......
THis will get very ugly because this is a pump being set up for a P.O ....betcha ; ) Currently at $4 on 12.6 million shares
(476)
•••
Iseneschal
X
Post by
Iseneschal
on Jun 03, 2024 9:18am
BPTH.....Early a.m runner on NR this a.m
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting 2024-06
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 15, 2024 7:00am
New Press Release - Bio-Path Holdings Reports First Quarter 2024 Financial Results
Marks Progress Across Key Clinical and Corporate Goals Strengthened Balance Sheet with $3.5 Million Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, May 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize...
read article.
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine